Followers | 125 |
Posts | 7319 |
Boards Moderated | 1 |
Alias Born | 12/03/2017 |
Monday, April 29, 2024 9:47:30 AM
Anyway, my point is that I too, would really like to know the answer to this question. The answer would determine whether or not I buy back in or wave farewell to ENZC forever. C3, along with my "original belief" about Charles (That he was an honest CEO who had shareholders best interest in mind), are the main reasons I held 3-4 years+, instead of cashing out what would have been life-changing $$$ for me. Biggest lesson I've learned since I began trading, and still hard to swallow.
My dilemma is that I still believe in C3, but:
1. We've heard nothing about it in years. What happened to the tests? What happened with ENZO the monkey? Was he cured?
2. Does BGEN own C3 now, and if so, will BGEN move forward under ENZC, or will they screw us with some other SPAC/selling off to somebody else?
3. What is Charles role in all of this? If BGEN does own C3, I just can't see Charles allowing C3 to move forward without him.
Anyway, like I said, murky at best.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM